Timothy J Daskivich

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint Comorbidity and competing risks for mortality in men with prostate cancer
    Timothy J Daskivich
    Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, USA
    Cancer 117:4642-50. 2011
  2. doi request reprint Overtreatment of men with low-risk prostate cancer and significant comorbidity
    Timothy J Daskivich
    Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, California, USA
    Cancer 117:2058-66. 2011
  3. doi request reprint Improved prediction of long-term, other cause mortality in men with prostate cancer
    Timothy J Daskivich
    Department of Urology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095 1738, USA
    J Urol 186:1868-73. 2011
  4. pmc Comorbidities, treatment and ensuing survival in men with prostate cancer
    Karim Chamie
    UCLA Department of Urology, Health Services Research Group, 924 Westwood Blvd, Suite 1000, Los Angeles, California 90024, USA
    J Gen Intern Med 27:492-9. 2012
  5. pmc Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer
    Timothy J Daskivich
    University of California, Los Angeles, Los Angeles, CA 90024, USA
    Ann Intern Med 158:709-17. 2013
  6. doi request reprint Bone scan overuse in staging of prostate cancer: an analysis of a Veterans Affairs cohort
    Roland Palvolgyi
    Department of Urology, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, California 90024, USA
    Urology 77:1330-6. 2011
  7. pmc Recurrence of high-risk bladder cancer: A population-based analysis
    Karim Chamie
    Department of Urology, Health Services Research Group, David Geffen School of Medicine at University of California Los Angeles UCLA, Los Angeles, California Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California
    Cancer 119:3219-27. 2013

Detail Information

Publications7

  1. doi request reprint Comorbidity and competing risks for mortality in men with prostate cancer
    Timothy J Daskivich
    Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, USA
    Cancer 117:4642-50. 2011
    ..The authors sought to assess the competing risks of nonprostate cancer and prostate cancer mortality among men with differing Charlson comorbidity index scores and tumor risks...
  2. doi request reprint Overtreatment of men with low-risk prostate cancer and significant comorbidity
    Timothy J Daskivich
    Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, California, USA
    Cancer 117:2058-66. 2011
    ..Men with low-risk prostate cancer and significant comorbidity are susceptible to overtreatment. The authors sought to compare the impact of comorbidity and age on treatment choice in men with low-risk disease...
  3. doi request reprint Improved prediction of long-term, other cause mortality in men with prostate cancer
    Timothy J Daskivich
    Department of Urology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095 1738, USA
    J Urol 186:1868-73. 2011
    ..We identified long-term risks of other cause mortality associated with comorbidities in the Charlson index and applied these to the creation of a prostate cancer specific comorbidity index...
  4. pmc Comorbidities, treatment and ensuing survival in men with prostate cancer
    Karim Chamie
    UCLA Department of Urology, Health Services Research Group, 924 Westwood Blvd, Suite 1000, Los Angeles, California 90024, USA
    J Gen Intern Med 27:492-9. 2012
    ..Comorbidity is poorly integrated into prostate cancer decision making...
  5. pmc Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer
    Timothy J Daskivich
    University of California, Los Angeles, Los Angeles, CA 90024, USA
    Ann Intern Med 158:709-17. 2013
    ..Accurate estimation of life expectancy is essential to offering appropriate care to men with early-stage prostate cancer, but mortality risks associated with comorbidity are poorly defined...
  6. doi request reprint Bone scan overuse in staging of prostate cancer: an analysis of a Veterans Affairs cohort
    Roland Palvolgyi
    Department of Urology, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, California 90024, USA
    Urology 77:1330-6. 2011
    ..With contemporary widespread prostate-specific antigen (PSA) screening, more patients are being diagnosed with low- and intermediate-risk prostate cancer, reducing the need and yield of bone scan imaging...
  7. pmc Recurrence of high-risk bladder cancer: A population-based analysis
    Karim Chamie
    Department of Urology, Health Services Research Group, David Geffen School of Medicine at University of California Los Angeles UCLA, Los Angeles, California Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California
    Cancer 119:3219-27. 2013
    ..The recurrence, progression, and bladder cancer-related mortality rates were examined in a cohort of individuals with high-grade non-muscle-invasive bladder cancer...